Ho So

1.1k total citations
58 papers, 558 citations indexed

About

Ho So is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, Ho So has authored 58 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 18 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Ho So's work include Rheumatoid Arthritis Research and Therapies (16 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Spondyloarthritis Studies and Treatments (11 papers). Ho So is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Spondyloarthritis Studies and Treatments (11 papers). Ho So collaborates with scholars based in China, Hong Kong and United Kingdom. Ho So's co-authors include Lai‐Shan Tam, Tommy Lam, Qian Mei, Peng Shang, Seung Hyun Lee, Steven Ho Man Lam, T. E. Oh, T. Buckley, Isaac T Cheng and Jacqueline So and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Ho So

53 papers receiving 551 citations

Peers

Countries citing papers authored by Ho So

Since Specialization

Citations

This map shows the geographic impact of Ho So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho So more than expected).

Fields of papers citing papers by Ho So

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho So. The network helps show where Ho So may publish in the future.

Co-authorship network of co-authors of Ho So

This figure shows the co-authorship network connecting the top 25 collaborators of Ho So. A scholar is included among the top collaborators of Ho So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho So. Ho So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bone microarchitecture assessed by 3D high-resolution peripheral quantitative computed tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced osteoporosis 2025 ·Journal of Orthopaedic Translation ·Ho So, James F. Griffith, (unknown), (unknown), (unknown), (unknown), Shirley King Yee Ying, (unknown), Crystal Ying Chan, Ling Qin, Lai‐Shan Tam	1
2	The 2024 APLAR Consensus on the Management of Lupus Nephritis 2025 ·International Journal of Rheumatic Diseases ·Chi Chiu Mok, Ho So, Laniyati Hamijoyo, Nuntana Kasitanon, Der‐Yuan Chen, Sang‐Cheol Bae, (unknown), Sandra Navarra, Desmond Y. H. Yap, Yoshiya Tanaka	4
3	Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study 2024 ·Seminars in Arthritis and Rheumatism ·(unknown), Steven Ho Man Lam, Ho So, (unknown), Lai‐Shan Tam	4
4	Management of bone health in idiopathic inflammatory myopathies: A two‐center audit in the United Kingdom and Hong Kong 2024 ·International Journal of Rheumatic Diseases ·(unknown), (unknown), (unknown), (unknown), Thomas Sheeran, (unknown), Ho So, Latika Gupta	1
5	Utility of multi-biomarker panel on discriminating disease activity in patients with psoriatic arthritis 2024 ·International Immunopharmacology ·Yingzhao Jin, Isaac T Cheng, Ho So, Martin Li, Terry Cheuk‐Fung Yip, Chun Kwok Wong, Lai‐Shan Tam	1
6	Validation of the International Myositis Assessment and Clinical Studies Group guideline on cancer risk stratification 2024 ·Lara D. Veeken ·(unknown), Shirley Chiu Wai Chan, Philip H. Li, (unknown), (unknown), Dennis Chan, (unknown), (unknown), (unknown), Victor Tang, Ho So	1
7	Moderate and high disease activity levels increase the risk of subclinical atherosclerosis progression in early rheumatoid arthritis: a 5-year prospective study 2024 ·RMD Open ·(unknown), Isaac T Cheng, (unknown), (unknown), Ho So, Lai‐Shan Tam	1
8	Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients 2024 ·Therapeutic Advances in Musculoskeletal Disease ·(unknown), Ho So, Steven Ho Man Lam, Tena K. Li, (unknown), Cheuk‐Chun Szeto, Lai‐Shan Tam	0
9	Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study 2023 ·Annals of the Rheumatic Diseases ·Ho So, Tommy Lam, (unknown), Steven Ho Man Lam, Lai‐Shan Tam	29
10	AB0298 SAFETY OF THE JAK INHIBITORS IN COMPARISON WITH THE TNF INHIBITORS IN RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM THE HONG KONG BIOLOGICS REGISTRY 2023 ·Annals of the Rheumatic Diseases ·(unknown), Ho So, Chien Ho	1
11	The Hong Kong Society of Rheumatology consensus recommendations for the management of gout 2023 ·Clinical Rheumatology ·(unknown), TT Cheung, Ho So, (unknown), (unknown), Helen Hoi Lun Tsang, (unknown), (unknown), (unknown)	4
12	Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial 2022 ·Lupus ·Ho So, Evelyn J. Chow, Isaac T Cheng, (unknown), Tena K. Li, Cheuk‐Chun Szeto, Lai‐Shan Tam	13
13	Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti–Melanoma Differentiation–Associated Protein 5 Positivity 2022 ·Arthritis & Rheumatology ·Ho So, Jacqueline So, Tommy Lam, (unknown), (unknown), (unknown), Chi Chiu Mok, Chak Sing Lau, Lai‐Shan Tam	10
14	Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis 2022 ·Frontiers in Medicine ·Ho So, Jacqueline So, Tommy Lam, (unknown), (unknown), (unknown), Chak Sing Lau, Lai‐Shan Tam	11
15	Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis 2022 ·Frontiers in Medicine ·Isaac T Cheng, Huan Meng, Martin Li, Edmund K. Li, Priscilla Wong, J. Jack Lee, Bryan P. Yan, Alex Pui‐Wai Lee, Ho So, Lai‐Shan Tam	3
16	Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial 2021 ·Annals of the Rheumatic Diseases ·Ho So, Isaac T Cheng, (unknown), Evelyn J. Chow, Tommy Lam, Vivian Hung, Edmund K. Li, James F. Griffith, Vivian Lee, Lin Shi, Junbin Huang, (unknown), (unknown), Tena K. Li, Vincent Lo, (unknown), (unknown), Ling Qin, Lai‐Shan Tam	15
17	Myositis‐specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies 2020 ·Acta Neurologica Scandinavica ·(unknown), Ho So, Tommy Lam, (unknown)	19
18	The first case of idiopathic inflammatory myopathy complicated by Epstein‐Barr virus‐associated smooth muscle tumor and lymphoma 2019 ·International Journal of Rheumatic Diseases ·Ho So, (unknown), (unknown), (unknown), (unknown)	2
19	Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis 2018 ·Clinical Rheumatology ·Ho So, (unknown), (unknown), (unknown), (unknown)	73
20	Acute myocardial infarction and subclavian artery occlusion in a 41-year-old woman with Behçet’s disease: coronary and large vessel arteritis 2014 ·Singapore Medical Journal ·Ho So, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact